Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Studies Overturn Premise that Growth Factors Are Best Approach to Healing Chronic Wounds

Discussion in 'Diabetic Foot & Wound Management' started by NewsBot, Oct 26, 2011.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Genetic Engineering & Biotechnology News are reporting:
    Studies Overturn Premise that Growth Factors Are Best Approach to Healing Chronic Wounds
    Full article

    A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice
    Chieh-Fang Chenget al
    J Clin Invest
     
  2. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.
    Yera Alos IB, Alonso-Carbonell L, Valenzuela-Silva CM, Tuero-Iglesias AD, Moreira-Martínez M, Marrero-Rodríguez I, López-Mola E, López-Saura PA.
    BMC Pharmacol Toxicol. 2013 Sep 3;14(1):44
     
  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    In vitro and in vivo epidermal growth factor gene therapy for diabetic ulcers with electrospun fibrous meshes.
    Kim HS, Yoo HS.
    Acta Biomater. 2013 Jul;9(7):7371-80.
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial.
    Gomez-Villa R, Aguilar-Rebolledo F, Lozano-Platonoff A, Teran-Soto JM, Fabian-Victoriano MR, Kresch-Tronik NS, Garrido-Espíndola X, Garcia-Solis A, Bondani-Guasti A, Bierzwinsky-Sneider G, Wound Repair Regen. 2014 Jul;22(4):497-503.
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction
    Ariana Garcia Ojalvo et al
    International Wound Journal; Early View
     
Loading...

Share This Page